Global Thematic Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Global Thematic Partners’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-782,452	Closed	-$31.6M	–	88
2015 Q3	$31.6M	Sell	782,452 -20,104	-3%	-$1.04M	0.53%	57
2015 Q2	$46.2M	Sell	802,556 -64,214	-7%	-$4.08M	0.61%	52
2015 Q1	$55.2M	Buy	866,770 +25,294	+3%	+$1.72M	0.83%	46
2014 Q4	$52M	Sell	841,476 -5,720	-0.7%	-$282K	0.82%	42
2014 Q3	$32.9M	Sell	847,196 -8,770	-1%	-$311K	0.5%	62
2014 Q2	$29.5M	Buy	+855,966	New	+$27M	0.45%	58

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Global Thematic Partners's IONS Position: Q4 2015 in Review

Global Thematic Partners sold out of Ionis Pharmaceuticals (IONS) in Q4 2015, closing a stake of 782,452 shares — an estimated $31.6M sold.

Global Thematic Partners first reported a position in IONS in Q2 2014 and held it in 6 quarters. The position peaked at $55.2M in Q1 2015. 334 funds tracked by Wall St. Rank hold IONS as of Q4 2015.

Global Thematic Partners reported no remaining Ionis Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Global Thematic Partners sold 782,452 Ionis Pharmaceuticals shares in Q4 2015, an estimated $31.6M.
Global Thematic Partners first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 6 quarters.
Global Thematic Partners's Ionis Pharmaceuticals position peaked at $55.2M in Q1 2015.
334 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2015.

Based on Global Thematic Partners's 13F filing for Q4 2015, filed 26 Jan 2016.